Literature DB >> 20643771

β2-Adrenergic receptor desensitization in perirenal adipose tissue in fetuses and lambs with placental insufficiency-induced intrauterine growth restriction.

Xiaochuan Chen1, Anna L Fahy, Alice S Green, Miranda J Anderson, Robert P Rhoads, Sean W Limesand.   

Abstract

Placental insufficiency-induced intrauterine growth restriction (IUGR) fetuses have chronic hypoxaemia and elevated plasma catecholamine concentrations. In this study, we determined whether adrenergic responsiveness becomes desensitized in the perirenal adipose tissue of IUGR fetuses and lambs by measuring adrenergic receptor (AR) mRNA and protein levels. We also tested the ability of adrenaline to mobilize non-esterified fatty acids (NEFAs) in young lambs. Perirenal adipose tissue was collected from IUGR and control fetuses at 133 days of gestational age (dGA) and lambs at 18 days of age (dA). β(2)-AR mRNA concentrations were 59% and 74% lower (P < 0.05) in IUGR fetuses and lambs compared to controls, respectively, which also resulted in lower protein levels (P < 0.05). No treatment differences were detected for α(1A)-, α(1B)-, α(1D)-, α(2A)-, α(2B)-, α(2C)-, β(1)- and β(3)-AR expression. mRNA concentrations were also determined for hormone sensitive lipase (HSL), perilipin (lipid droplet-associated protein), and two adipokines, leptin and adiponectin. Adiponectin and HSL were not different between treatments at either age. Compared to controls, perilipin and leptin mRNA concentrations were lower (P < 0.05) in IUGR fetuses but not in lambs. Because of the β(2)-AR results, we challenged a second cohort of lambs with exogenous adrenaline at 21 dA. The ability of adrenaline to mobilize NEFA was 55 ± 15% lower (P < 0.05) in IUGRs than controls. Collectively, our findings indicate that elevated catecholamine exposure in utero causes desensitization of adipose tissue by down-regulation of β(2)-AR, and this persists in lambs. This impairment in adrenergic stimulated lipolysis might partially explain early onset obesity in IUGR offspring.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643771      PMCID: PMC2988517          DOI: 10.1113/jphysiol.2010.192310

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Relationship of fetal growth to duration of heat stress in an ovine model of placental insufficiency.

Authors:  H L Galan; M J Hussey; A Barbera; E Ferrazzi; M Chung; J C Hobbins; F C Battaglia
Journal:  Am J Obstet Gynecol       Date:  1999-05       Impact factor: 8.661

3.  Increased insulin sensitivity and maintenance of glucose utilization rates in fetal sheep with placental insufficiency and intrauterine growth restriction.

Authors:  Sean W Limesand; Paul J Rozance; Danielle Smith; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-25       Impact factor: 4.310

Review 4.  Regulation of G protein-coupled receptors by agonist-dependent phosphorylation.

Authors:  J L Benovic; J J Onorato; M G Caron; R J Lefkowitz
Journal:  Soc Gen Physiol Ser       Date:  1990

5.  Catecholamines inhibit growth in fetal sheep in the absence of hypoxemia.

Authors:  J M Bassett; C Hanson
Journal:  Am J Physiol       Date:  1998-06

6.  Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction.

Authors:  Sean W Limesand; Paul J Rozance; Gary O Zerbe; John C Hutton; William W Hay
Journal:  Endocrinology       Date:  2005-12-08       Impact factor: 4.736

Review 7.  Endocrine and nutritional regulation of fetal adipose tissue development.

Authors:  M E Symonds; A Mostyn; S Pearce; H Budge; T Stephenson
Journal:  J Endocrinol       Date:  2003-12       Impact factor: 4.286

8.  Beta2-agonist ritodrine, unlike natural catecholamines, activates thermogenesis prematurely in fetal sheep.

Authors:  J M Bassett; M E Symonds
Journal:  Am J Physiol       Date:  1998-07

9.  Body mass index during childhood and adult body composition in men and women aged 56-70 y.

Authors:  Hilkka Ylihärsilä; Eero Kajantie; Clive Osmond; Tom Forsén; David Jp Barker; Johan G Eriksson
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

10.  Regulation of beta 2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition.

Authors:  K Hosoda; L R Fitzgerald; V A Vaidya; G K Feussner; P H Fishman; R S Duman
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.054

View more
  24 in total

1.  Intrauterine growth-restricted sheep fetuses exhibit smaller hindlimb muscle fibers and lower proportions of insulin-sensitive Type I fibers near term.

Authors:  Dustin T Yates; Caitlin N Cadaret; Kristin A Beede; Hannah E Riley; Antoni R Macko; Miranda J Anderson; Leticia E Camacho; Sean W Limesand
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

2.  Myoblasts from intrauterine growth-restricted sheep fetuses exhibit intrinsic deficiencies in proliferation that contribute to smaller semitendinosus myofibres.

Authors:  Dustin T Yates; Derek S Clarke; Antoni R Macko; Miranda J Anderson; Leslie A Shelton; Marie Nearing; Ronald E Allen; Robert P Rhoads; Sean W Limesand
Journal:  J Physiol       Date:  2014-05-23       Impact factor: 5.182

3.  Elevated plasma norepinephrine inhibits insulin secretion, but adrenergic blockade reveals enhanced β-cell responsiveness in an ovine model of placental insufficiency at 0.7 of gestation.

Authors:  A R Macko; D T Yates; X Chen; A S Green; A C Kelly; L D Brown; S W Limesand
Journal:  J Dev Orig Health Dis       Date:  2013-10       Impact factor: 2.401

4.  Chronic pulsatile hyperglycemia reduces insulin secretion and increases accumulation of reactive oxygen species in fetal sheep islets.

Authors:  Alice S Green; Xiaochuan Chen; Antoni R Macko; Miranda J Anderson; Amy C Kelly; Nathaniel J Hart; Ronald M Lynch; Sean W Limesand
Journal:  J Endocrinol       Date:  2011-12-19       Impact factor: 4.286

5.  Islet adaptations in fetal sheep persist following chronic exposure to high norepinephrine.

Authors:  Xiaochuan Chen; Amy C Kelly; Dustin T Yates; Antoni R Macko; Ronald M Lynch; Sean W Limesand
Journal:  J Endocrinol       Date:  2016-11-25       Impact factor: 4.286

6.  Enhanced insulin secretion and insulin sensitivity in young lambs with placental insufficiency-induced intrauterine growth restriction.

Authors:  Leticia E Camacho; Xiaochuan Chen; William W Hay; Sean W Limesand
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-05-10       Impact factor: 3.619

7.  Enhanced insulin secretion responsiveness and islet adrenergic desensitization after chronic norepinephrine suppression is discontinued in fetal sheep.

Authors:  Xiaochuan Chen; Alice S Green; Antoni R Macko; Dustin T Yates; Amy C Kelly; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-19       Impact factor: 4.310

8.  PHYSIOLOGY SYMPOSIUM: Effects of heat stress during late gestation on the dam and its calf12.

Authors:  Sha Tao; Geoffrey E Dahl; Jimena Laporta; John K Bernard; Ruth M Orellana Rivas; Thiago N Marins
Journal:  J Anim Sci       Date:  2019-04-29       Impact factor: 3.159

9.  Adrenal Demedullation and Oxygen Supplementation Independently Increase Glucose-Stimulated Insulin Concentrations in Fetal Sheep With Intrauterine Growth Restriction.

Authors:  Antoni R Macko; Dustin T Yates; Xiaochuan Chen; Leslie A Shelton; Amy C Kelly; Melissa A Davis; Leticia E Camacho; Miranda J Anderson; Sean W Limesand
Journal:  Endocrinology       Date:  2016-03-03       Impact factor: 4.736

10.  Insulin-like growth factor and fibroblast growth factor expression profiles in growth-restricted fetal sheep pancreas.

Authors:  Xiaochuan Chen; Paul J Rozance; William W Hay; Sean W Limesand
Journal:  Exp Biol Med (Maywood)       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.